Therapeutic Potential of Kaempferol against Sleep Deprivation-Induced Cognitive Impairment: Modulation of Neuroinflammation and Synaptic Plasticity Disruption in Mice
ACS Pharmacology & Translational Science · 08.12.2023 · 6 (12) · 1934-1944
DOI: 10.1021/acsptsci.3c00226 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Pharmacology & Translational Science, online erschienen am 30.11.2023. Verfasst von Ya-Ya Du und 6 weiteren Autor:innen. Beteiligte Einrichtung: Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, The Fourth Military Medical University, Xi'an 710038, China. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Sleep deprivation (SD) has led to a rise in cognitive impairment (CI) cases. Kaempferol (KMP), known for its anti-inflammatory and antiapoptotic properties, holds promise in countering SD-induced CI. Experimental validation using a sleep-deprived CI model confirmed KMP's efficacy in mitigating CI. Immunofluorescence investigations emphasized diminished activation of astrocytes and reduced the proliferation of microglia in the hippocampus of mice subjected to SD. Subsequently, network pharmacological analyses were conducted and found that KMP may be closely related to the mitogen-activated protein kinase (MAPK) pathway in SD-induced CI. The influence of KMP on the MAPK pathway was verified by the observed decrease in the expression of phosphorylated JNK (p-JNK) and p38 (p-p38). Analyzing hippocampal AMPARS and NMDARS expression indicated KMP's ability to enhance GluA1 phosphorylation (Ser831 and Ser845) and GluN2A levels. Patch clamp assays demonstrated heightened excitatory transmitter transmission in the hippocampus, suggesting KMP's positive influence. Overall, KMP combats neuroinflammation via MAPK inhibition, augments synaptic function, and addresses learning and memory dysfunction in sleep-deprived mice.
Autor:innen und Institutionen
- Precision Pharmacy & Drug Development Center, Department of Pharmacy, Tangdu Hospital, The Fourth Military Medical University, Xi'an 710038, China.
- School of Pharmacy, Shaanxi University of Chinese Medicine, Xianyang 712046, China.
ORCID-Profile: Lan-Xin Luo
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Du, Y. Y., Sun, T., Yang, Q., Liu, Q. Q., Li, J. M., Yang, L., & Luo, L. X. (2023). Therapeutic Potential of Kaempferol against Sleep Deprivation-Induced Cognitive Impairment: Modulation of Neuroinflammation and Synaptic Plasticity Disruption in Mice. ACS Pharmacology & Translational Science, 6(12), 1934-1944. https://doi.org/10.1021/acsptsci.3c00226
Vancouver
Du YY, Sun T, Yang Q, Liu QQ, Li JM, Yang L, et al. Therapeutic Potential of Kaempferol against Sleep Deprivation-Induced Cognitive Impairment: Modulation of Neuroinflammation and Synaptic Plasticity Disruption in Mice. ACS Pharmacology & Translational Science. 2023;6(12):1934-1944. doi:10.1021/acsptsci.3c00226
BibTeX
@article{Du2023,
author = {Du, Ya-Ya and Sun, Ting and Yang, Qi and Liu, Qing-Qing and Li, Jia-Min and Yang, Le and Luo, Lan-Xin},
title = {Therapeutic Potential of Kaempferol against Sleep Deprivation-Induced Cognitive Impairment: Modulation of Neuroinflammation and Synaptic Plasticity Disruption in Mice},
journal = {ACS Pharmacology & Translational Science},
year = {2023},
volume = {6},
number = {12},
pages = {1934--1944},
doi = {10.1021/acsptsci.3c00226}
}
EUVIMED